Compare FULC & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULC | BRBS |
|---|---|---|
| Founded | 2015 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.8M | 392.4M |
| IPO Year | 2019 | 2015 |
| Metric | FULC | BRBS |
|---|---|---|
| Price | $6.98 | $3.47 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $16.38 | N/A |
| AVG Volume (30 Days) | ★ 677.6K | 382.9K |
| Earning Date | 04-27-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 24.78% |
| EPS Growth | N/A | ★ 135.48 |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $111,284,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $350.50 |
| Revenue Growth | N/A | ★ 123.99 |
| 52 Week Low | $5.47 | $3.33 |
| 52 Week High | $15.74 | $4.79 |
| Indicator | FULC | BRBS |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 38.64 |
| Support Level | $6.39 | $3.42 |
| Resistance Level | $7.09 | $3.71 |
| Average True Range (ATR) | 0.47 | 0.07 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 10.81 | 29.17 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.